CYFUSE BIOMEDICAL K K: Notice regarding adoption and participation in the AMED public offering project “Bridging Research Program”
Cyfuse Biomedical KK: Matters relating to business plans and growth potential
Cyfuse: Notice regarding the recording of non-operating income
Cyfuse: World's First 3D Neural Conduit Transplantation for Peripheral Nerve Injury - Doctor-Led Clinical Trial Results and Toward Social Implementation
Cyfuse Biomedical KK: Notice Concerning the Recording of Non-Operating Profit
Cyfuse Biomedical KK: Notice Concerning the Recording of Non-Operating Profit
Cyfuse Biomedical KK: Concluded a basic agreement on a business partnership
Cyfuse Biomedical KK: Notice regarding participation in the AMED public offering project “Regeneration/Cell Medicine/Gene Therapy Realization Acceleration Program”
Cyfuse Biomedical KK: Notice Concerning the Recording of Non-Operating Profit
Cyfuse Biomedical KK: Results of physician-led clinical trials of three-dimensional neural conduit transplantation
Cyfuse Biomedical KK: Matters relating to business plans and growth potential
Cyfuse Biomedical KK: Articles of Incorporation 2023/03/28
Cyfuse Biomedical KK: To conclude a basic agreement on cooperation for the purpose of developing regenerative medicine.
Cyfuse Biomedical KK: Notice on the Stock Remuneration system with transfer restrictions on Directors
Cyfuse Biomedical KK: Notice of partial change of articles of association
Cyfuse Biomedical KK: Notice on the inclusion of non-operating income
Cyfuse Biomedical KK: (new) report on revised securities reports for listing applications
Cyfuse Biomedical KK: Notice of independent director
Cyfuse Biomedical KK: Articles of association 2022-09-02
Cyfuse Biomedical KK: Notice of the company's settlement information accompanied by the listing on the Gross market of the Tokyo Stock Exchange
No Data